CN1438237A - 刺囊酸的制备方法、药物制剂及医药新用途 - Google Patents
刺囊酸的制备方法、药物制剂及医药新用途 Download PDFInfo
- Publication number
- CN1438237A CN1438237A CN 03100676 CN03100676A CN1438237A CN 1438237 A CN1438237 A CN 1438237A CN 03100676 CN03100676 CN 03100676 CN 03100676 A CN03100676 A CN 03100676A CN 1438237 A CN1438237 A CN 1438237A
- Authority
- CN
- China
- Prior art keywords
- ethanol
- filter
- echinocystic acid
- acid
- filtrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YKOPWPOFWMYZJZ-FMMUPTMQSA-N Echinocystic acid Natural products C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)C[C@H](O)[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C YKOPWPOFWMYZJZ-FMMUPTMQSA-N 0.000 title claims abstract description 72
- YKOPWPOFWMYZJZ-UHFFFAOYSA-N Echinocystsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C YKOPWPOFWMYZJZ-UHFFFAOYSA-N 0.000 title claims abstract description 72
- MCHWKJRTMPIHRA-UHFFFAOYSA-N n-(pyrrolidin-2-ylmethyl)aniline Chemical compound C1CCNC1CNC1=CC=CC=C1 MCHWKJRTMPIHRA-UHFFFAOYSA-N 0.000 title claims abstract description 72
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 132
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 17
- 210000004351 coronary vessel Anatomy 0.000 claims abstract description 11
- 206010002383 Angina Pectoris Diseases 0.000 claims abstract description 10
- 208000029078 coronary artery disease Diseases 0.000 claims abstract description 8
- 238000000746 purification Methods 0.000 claims abstract description 5
- 239000011347 resin Substances 0.000 claims abstract description 5
- 229920005989 resin Polymers 0.000 claims abstract description 5
- 235000019441 ethanol Nutrition 0.000 claims description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 239000000243 solution Substances 0.000 claims description 28
- 241000931143 Gleditsia sinensis Species 0.000 claims description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 24
- 230000006837 decompression Effects 0.000 claims description 16
- 239000008367 deionised water Substances 0.000 claims description 16
- 229910021641 deionized water Inorganic materials 0.000 claims description 16
- 239000012065 filter cake Substances 0.000 claims description 16
- 238000010992 reflux Methods 0.000 claims description 16
- 208000031225 myocardial ischemia Diseases 0.000 claims description 15
- 230000007062 hydrolysis Effects 0.000 claims description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims description 12
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 12
- 229930182490 saponin Natural products 0.000 claims description 12
- 150000007949 saponins Chemical class 0.000 claims description 12
- 235000017709 saponins Nutrition 0.000 claims description 12
- 239000013078 crystal Substances 0.000 claims description 10
- 239000012043 crude product Substances 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 238000001953 recrystallisation Methods 0.000 claims description 8
- 238000004064 recycling Methods 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 239000003463 adsorbent Substances 0.000 claims description 4
- 210000000481 breast Anatomy 0.000 claims description 4
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 4
- 239000000920 calcium hydroxide Substances 0.000 claims description 4
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 4
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000292 calcium oxide Substances 0.000 claims description 4
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 2
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 210000004165 myocardium Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 239000000284 extract Substances 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract description 2
- 229930182478 glucoside Natural products 0.000 abstract 1
- 150000008131 glucosides Chemical class 0.000 abstract 1
- 239000012264 purified product Substances 0.000 abstract 1
- 239000000344 soap Substances 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000002994 raw material Substances 0.000 description 6
- 206010061216 Infarction Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000007574 infarction Effects 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000008899 fufang danshen Substances 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000012266 salt solution Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000002183 duodenal effect Effects 0.000 description 3
- 210000001198 duodenum Anatomy 0.000 description 3
- 210000003516 pericardium Anatomy 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003191 femoral vein Anatomy 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- ZGZLYKUHYXFIIO-UHFFFAOYSA-N 5-nitro-2h-tetrazole Chemical compound [O-][N+](=O)C=1N=NNN=1 ZGZLYKUHYXFIIO-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000533849 Gleditsia Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000009524 danshen dripping Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03100676 CN1216896C (zh) | 2003-01-21 | 2003-01-21 | 刺囊酸的制备方法、药物制剂及医药新用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03100676 CN1216896C (zh) | 2003-01-21 | 2003-01-21 | 刺囊酸的制备方法、药物制剂及医药新用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1438237A true CN1438237A (zh) | 2003-08-27 |
CN1216896C CN1216896C (zh) | 2005-08-31 |
Family
ID=27673807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03100676 Expired - Lifetime CN1216896C (zh) | 2003-01-21 | 2003-01-21 | 刺囊酸的制备方法、药物制剂及医药新用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1216896C (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010130152A1 (zh) * | 2009-05-15 | 2010-11-18 | 成都康弘制药有限公司 | 一种治疗心血管疾病的药物组合物及其应用 |
CN102240293A (zh) * | 2010-05-11 | 2011-11-16 | 成都康弘制药有限公司 | 刺囊酸在制备预防和治疗心血管疾病的药物中的应用 |
CN101919901B (zh) * | 2009-06-10 | 2012-01-11 | 赵全成 | 皂角总苷元在制备α-葡萄糖苷酶抑制剂的药物中的应用 |
CN102464698A (zh) * | 2010-11-19 | 2012-05-23 | 苏州宝泽堂医药科技有限公司 | 一种高含量刺囊酸的制备方法 |
CN103145790A (zh) * | 2013-03-18 | 2013-06-12 | 山东省中医药研究院 | 从猪牙皂中同时制备齐墩果酸和刺囊酸的方法 |
WO2014063441A1 (zh) * | 2012-10-22 | 2014-05-01 | 北京大学 | 三萜衍生物及其抗流感用途 |
CN106550942A (zh) * | 2016-10-17 | 2017-04-05 | 徐州得铸生物科技有限公司 | 一种含1,8‑桉叶素的杀菌组合物 |
CN110563792A (zh) * | 2019-09-09 | 2019-12-13 | 南开大学 | G蛋白偶联胆汁酸受体激动剂及其应用 |
-
2003
- 2003-01-21 CN CN 03100676 patent/CN1216896C/zh not_active Expired - Lifetime
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010130152A1 (zh) * | 2009-05-15 | 2010-11-18 | 成都康弘制药有限公司 | 一种治疗心血管疾病的药物组合物及其应用 |
JP2012526730A (ja) * | 2009-05-15 | 2012-11-01 | 成都康弘制薬有限公司 | 心血管障害の治療用医薬組成物及びその使用 |
CN101919901B (zh) * | 2009-06-10 | 2012-01-11 | 赵全成 | 皂角总苷元在制备α-葡萄糖苷酶抑制剂的药物中的应用 |
CN102240293A (zh) * | 2010-05-11 | 2011-11-16 | 成都康弘制药有限公司 | 刺囊酸在制备预防和治疗心血管疾病的药物中的应用 |
CN102240293B (zh) * | 2010-05-11 | 2013-04-24 | 成都康弘制药有限公司 | 刺囊酸在制备预防和治疗心血管疾病的药物中的应用 |
CN102464698A (zh) * | 2010-11-19 | 2012-05-23 | 苏州宝泽堂医药科技有限公司 | 一种高含量刺囊酸的制备方法 |
JP2015535222A (ja) * | 2012-10-22 | 2015-12-10 | 北京大学 | トリテルペン誘導体とその抗インフルエンザへの使用 |
WO2014063441A1 (zh) * | 2012-10-22 | 2014-05-01 | 北京大学 | 三萜衍生物及其抗流感用途 |
CN103768078A (zh) * | 2012-10-22 | 2014-05-07 | 北京大学 | 三萜衍生物及其抗流感用途 |
EP2910563A4 (en) * | 2012-10-22 | 2016-05-25 | Univ Beijing | TRITERPENE DERIVATIVE AND ANTIGRIPPAL USE THEREOF |
US9920088B2 (en) | 2012-10-22 | 2018-03-20 | University of Macao | Triterpene derivative and its anti-influenza use |
CN103768078B (zh) * | 2012-10-22 | 2019-02-05 | 北京大学 | 三萜衍生物及其抗流感用途 |
CN103145790A (zh) * | 2013-03-18 | 2013-06-12 | 山东省中医药研究院 | 从猪牙皂中同时制备齐墩果酸和刺囊酸的方法 |
CN106550942A (zh) * | 2016-10-17 | 2017-04-05 | 徐州得铸生物科技有限公司 | 一种含1,8‑桉叶素的杀菌组合物 |
CN110563792A (zh) * | 2019-09-09 | 2019-12-13 | 南开大学 | G蛋白偶联胆汁酸受体激动剂及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1216896C (zh) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1216896C (zh) | 刺囊酸的制备方法、药物制剂及医药新用途 | |
CN1210289C (zh) | 两头尖提取物的制备工艺和用途 | |
CN104940216B (zh) | 没食子酰葡萄糖苷类衍生物的应用及用于治疗高尿酸血症的药物组合物 | |
CN101919901B (zh) | 皂角总苷元在制备α-葡萄糖苷酶抑制剂的药物中的应用 | |
CN101307090B (zh) | 知母皂苷bⅲ的制备方法及其用途 | |
JP3128823B2 (ja) | 制癌化合物およびその製造法 | |
CN101564405A (zh) | 续断总苷元及单一成分常春藤皂苷元在制备α-葡萄糖苷酶抑制剂药物中的应用 | |
CN113861135B (zh) | 白木香四醇及其药物组合物与其制备方法和应用 | |
CN1114413C (zh) | 大黄素-8-O-β-D-葡萄糖苷的新用途 | |
CN1682746A (zh) | 抱茎苦荬菜黄酮类化合物在制备治疗冠心病药物中的应用 | |
CN100584345C (zh) | 具抗病毒作用的小紫金牛提取物及其提取方法和应用 | |
CN1282468C (zh) | 中药脑得生软胶囊及其制备方法 | |
CN1560061A (zh) | 怀山药提取物怀山药皂甙的提取方法 | |
CN1068790C (zh) | 含有西洋参茎叶总皂甙的药物组合物 | |
EP0014471B1 (en) | Acylated derivatives of a water extract of anemarrhenae rhizoma and hypoglycemic agents containing said derivatives | |
CN1923191B (zh) | 二氢黄酮类化合物在制备治疗心血管疾病药物中的应用 | |
CN101633661B (zh) | 制备斑蝥酸钠的工艺 | |
CN101249129B (zh) | 一种治疗糖尿病的中药提取物组合物及其医药用途 | |
CN1939327A (zh) | 柳川鱼苷、蒙花苷及其组合物的制药用途 | |
CN100355424C (zh) | 治疗糖尿病的楤木提取物及楤木皂苷在制备治疗糖尿病的药物中的应用 | |
CN112961203B (zh) | 黄酮醇苷衍生物及其用途和制备方法 | |
CN115737698B (zh) | 一种铁甲草提取物在抑制葡萄糖苷酶中的应用 | |
CN112500444B (zh) | 一种化合物及其制备方法和应用 | |
CN102070700A (zh) | 乌骨藤皂苷h及其制备方法与应用 | |
CN1064234C (zh) | 二咖啡酰氧基--奎宁酸在制药中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHENGDU KANGHONG TECHNOLOGY INDUSTRIAL (GROUP) CO Free format text: FORMER OWNER: TIANYAO SCIENCE AND TECHNOLOGY CO LTD, JILIN Effective date: 20060317 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20060317 Address after: 610036 No. 36 Shu West Road, Chengdu, Sichuan, Jinniu District Patentee after: Chengdu Kanghong technology industry (Group) Co.,Ltd. Address before: 130103 No. 509 Mao Xiang street, hi tech Development Zone, Jilin, Changchun Patentee before: JILIN TIANYAO SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: CHENGDU KANGHONG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: CHENGDU KANGHONG TECHNOLOGY INDUSTRIAL (GROUP) CO., LTD. Effective date: 20080912 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080912 Address after: No 36, Shu West Road, Chengdu, Sichuan, Jinniu District Patentee after: Chengdu Kanghong Pharmaceutical Co.,Ltd. Address before: No 36, Shu West Road, Chengdu, Sichuan, Jinniu District Patentee before: Chengdu Kanghong technology industry (Group) Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20050831 |
|
CX01 | Expiry of patent term |